Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

CVS quarterly profit beats; expects to close Aetna deal this month

11/06/2018 | 10:40am EDT
FILE PHOTO: Shoppers walk outside a CVS store and pharmacy in Medford

(Reuters) - CVS Health Corp, which expects to close its $69 billion purchase of Aetna Inc this month, reported third-quarter profit that beat analysts' estimates on higher sales of prescription drugs.

Shares of the drugstore chain and pharmacy benefit manager (PBM) were up 2.7 percent at $75.70 in morning trading.

The company said it believes the Aetna deal will help it save more than $750 million in costs in the second year after it closes, as the combination reduces corporate expenses as well as produces "some" cuts in medical costs from decreased emergency room visits.

"The longer term medical cost savings will come from new programs that are only made possible through the combination and close integration of our two companies," Chief Executive Officer Larry Menlo said on call with analysts.

CVS, which last month won U.S. Department of Justice approval to buy Aetna, said it reached agreement with the state of California on the acquisition and expects to finalize terms over the coming days. The deal is expected to close before the Thanksgiving holiday, which falls on Nov. 22, CVS said.

The combination is expected to reshape the healthcare sector as it brings together one of the largest PBMs and one of the nation's oldest health insurers.

CVS could offer more preventive care services and screenings to Aetna customers in its clinics, such as enabling diabetes patients to monitor blood sugar levels, avoiding higher cost visits to doctors or emergency rooms.

Pharmacy same-store sales rose 8.7 percent in the quarter, while analysts were expecting a 7.7 percent rise.

Front end of the store same-store sales rose 0.8 percent versus analysts' expectations of an 0.8 percent drop, despite brick-and-mortar drugstore chains like CVS coming under increasing pressure from consumer shifts to online options.

Sales of beauty products at CVS stores have benefited from promotions and newer offerings. Last year, the company announced a initiative to offer over a hundred new South Korean beauty brands at its stores.

Excluding items, CVS Health said it earned $1.73 per share, topping analysts' average estimates by 2 cents.

Net revenue rose 2.4 percent to $47.27 billion, beating expectation of $47.18 billion.

Net income rose to $1.39 billion, or $1.36 per share, in the quarter. Its income tax provision declined by $268 million. (https://bit.ly/2D48hy8)

(Reporting by Manas Mishra and Manogna Maddipatla in Bengaluru; Editing by Arun Koyyur and Bill Berkrot)

By Manas Mishra

ę Reuters 2018
Stocks mentioned in the article
ChangeLast1st jan.
CVS HEALTH CORPORATION 0.20% 87.9 Delayed Quote.28.37%
08:31aMore than 3 out of 4 Aetna Medicare Advantage members in 4.5 Star-rated plans or higher..
10/25Large employer group launches pharmacy benefit management business
10/25CVS HEALTH : Healthier Happens Together
10/22Walmart, Walgreens U.S. stores roll out Moderna, J&J COVID-19 booster shots
10/22CVS HEALTH : Pharmacies Start Offering Moderna COVID-19 Booster Shots
10/22CVS HEALTH : Announces Availability of Moderna Booster to Eligible Populations
10/22CVS Health Corporation Announces Availability of Moderna Booster to Eligible Population..
10/21CVS HEALTH CORPORATION : Ex-dividend day for
10/19REINVENTING HEALTH CARE : The Aetna Connected Plan with CVS Health™ is helping deliv..
10/18CVS Health Names Joneigh S. Khaldun as Chief Health Equity Officer
More news
Analyst Recommendations on CVS HEALTH CORPORATION
More recommendations
Financials (USD)
Sales 2021 284 B - -
Net income 2021 8 470 M - -
Net Debt 2021 48 981 M - -
P/E ratio 2021 13,7x
Yield 2021 2,27%
Capitalization 116 B 116 B -
EV / Sales 2021 0,58x
EV / Sales 2022 0,54x
Nbr of Employees 256 500
Free-Float 75,6%
Duration : Period :
CVS Health Corporation Technical Analysis Chart | CVS | US1266501006 | MarketScreener
Technical analysis trends CVS HEALTH CORPORATION
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 27
Last Close Price 87,68 $
Average target price 97,05 $
Spread / Average Target 10,7%
EPS Revisions
Managers and Directors
Karen S. Lynch President, Chief Executive Officer & Director
Shawn M. Guertin Chief Financial Officer & Executive Vice President
David Wyatt Dorman Chairman
Troyen A. Brennan Chief Medical Officer & Executive Vice President
Jonathan C. Roberts Chief Operating Officer & Executive Vice President